A Review of Clinical Applications for Super-resolution Ultrasound Localization Microscopy

Abstract

Microvascular structure and hemodynamics are important indicators for the diagnosis and assessment of many diseases and pathologies. The structural and functional imaging of tissue microvasculature in vivo is a clinically significant objective for the development of many imaging modalities. Contrast-enhanced ultrasound (CEUS) is a popular clinical tool for characterizing tissue microvasculature, due to the moderate cost, wide accessibility, and absence of ionizing radiation of ultrasound. However, in practice, it remains challenging to demonstrate microvasculature using CEUS, due to the resolution limit of conventional ultrasound imaging. In addition, the quantification of tissue perfusion by CEUS remains hindered by high operator-dependency and poor reproducibility. Inspired by super-resolution optical microscopy, super-resolution ultrasound localization microscopy (ULM) was recently developed. ULM uses the same ultrasound contrast agent (i.e. microbubbles) in CEUS. However, different from CEUS, ULM uses the location of the microbubbles to construct images, instead of using the backscattering intensity of microbubbles. Hence, ULM overcomes the classic compromise between imaging resolution and penetration, allowing for the visualization of capillary-scale microvasculature deep within tissues. To date, many in vivo ULM results have been reported, including both animal (kidney, brain, spinal cord, xenografted tumor, and ear) and human studies (prostate, tibialis anterior muscle, and breast cancer tumors). Furthermore, a variety of useful biomarkers have been derived from using ULM for different preclinical and clinical applications. Due to the high spatial resolution and accurate blood flow speed estimation (approximately 1 mm/s to several cm/s), ULM presents as an enticing alternative to CEUS for characterizing tissue microvasculature in vivo. This review summarizes the principles and present applications of CEUS and ULM, and discusses areas where ULM can potentially provide a better alternative to CEUS in clinical practice and areas where ULM may not be a better alternative. The objective of the study is to provide clinicians with an up-to-date review of ULM technology, and a practical guide for implementing ULM in clinical research and practice.

Keywords

contrast-enhanced ultrasound / super-resolution / ultrasound / microvascular imaging / microbubbles

References

[1] DietrichCF, SirlinCB, O’BoyleM, et al.. Editorial on the Current Role of Ultrasound. Appl Sci, 2019, 9(17): 3512

[2] FeinsteinSB. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol, 2004, 287(2): H450-457

[3] ClaudonM, DietrichCF, ChoiBI, et al.. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol, 2013, 39(2): 187-210

[4] SidhuPS, CantisaniV, DietrichCF, et al.. The EFSUMB Guidelines and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version). Ultraschall Med, 2018, 39(2): e2-e44

[5] ChongWK, PapadopoulouV, DaytonPA. Imaging with ultrasound contrast agents: current status and future. Abdom Radiol (NY), 2018, 43(4): 762-772

[6] FeinsteinSB, CollB, StaubD, et al.. Contrast enhanced ultrasound imaging. J Nucl Cardiol, 2010, 17(1): 106-115

[7] GreisC. Technology overview: SonoVue (Bracco, Milan). Eur Radiol, 2004, 14(Suppl8): 11-15

[8] IgneeA, AtkinsonNS, SchuesslerG, et al.. Ultrasound contrast agents. Endosc Ultrasound, 2016, 5(6): 355-362

[9] FurlowB. Contrast-enhanced ultrasound. Radiol Technol, 2009, 80(6): 547S-561S

[10] DietrichCF, AverkiouM, NielsenMB, et al.. How to perform contrast-enhanced ultrasound (CEUS). Ultrasound Int Open, 2018, 4(1): E2-E15

[11] RanganathPG, RobbinML, BackSJ, et al.. Practical advantages of contrast-enhanced ultrasound in abdominopelvic radiology. Abdom Radiol (NY), 2018, 43(4): 998-1012

[12] ChioreanL, TanaC, BradenB, et al.. Advantages and Limitations of Focal Liver Lesion Assessment with Ultrasound Contrast Agents: Comments on the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines. Med Princ Pract, 2016, 25(5): 399-407

[13] BriguoriC, TavanoD, ColomboA. Contrast agent— associated nephrotoxicity. Prog Cardiovasc Dis, 2003, 45(6): 493-503

[14] SchraderR. Contrast material-induced renal failure: an overview. J Interv Cardiol, 2005, 18(6): 417-423

[15] WaikarSS, LiuKD, ChertowGM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol, 2008, 3(3): 844-861

[16] BaileyC, HuismanT, de JongRM, et al.. Contrast-Enhanced Ultrasound and Elastography Imaging of the Neonatal Brain: A Review. J Neuroimaging, 2017, 27(5): 437-441

[17] WeberMA, KrixM, DelormeS. Quantitative evaluation of muscle perfusion with CEUS and with MR. Eur Radiol, 2007, 17(10): 2663-2674

[18] GreisC. Quantitative evaluation of microvascular blood flow by contrast-enhanced ultrasound (CEUS). Clin Hemorheol Microcirc, 2011, 49(1–4): 137-149

[19] AverkiouM, LampaskisM, KyriakopoulouK, et al.. Quantification of tumor microvascularity with respiratory gated contrast enhanced ultrasound for monitoring therapy. Ultrasound Med Biol, 2010, 36(1): 68-77

[20] CaoW, CuiS, YangL, et al.. Contrast-Enhanced Ultrasound for Assessing Renal Perfusion Impairment and Predicting Acute Kidney Injury to Chronic Kidney Disease Progression. Antioxid Redox Signal, 2017, 27(17): 1397-1411

[21] WilsonSR, BurnsPN, KonoY. Contrast-Enhanced Ultrasound of Focal Liver Masses: A Success Story. Ultrasound Med Biol, 2020, 46(5): 1059-1070

[22] GummadiS, EisenbreyJR, LyshchikA. Contrast-enhanced ultrasonography in interventional oncology. Abdom Radiol (NY), 2018, 43(11): 3166-3175

[23] KessnerR, NakamotoDA, KondrayV, et al.. Contrast-Enhanced Ultrasound Guidance for Interventional Procedures. J Ultrasound Med, 2019, 38(10): 2541-2557

[24] TangMX, MulvanaH, GauthierT, et al.. Quantitative contrast-enhanced ultrasound imaging: a review of sources of variability. Interface Focus, 2011, 1(4): 520-539

[25] ErricoC, PierreJ, PezetS, et al.. Ultrafast ultrasound localization microscopy for deep super-resolution vascular imaging. Nature, 2015, 527(7579): 499-502

[26] BouakazA, FrigstadS, Ten CateFJ, et al.. Super harmonic imaging: a new imaging technique for improved contrast detection. Ultrasound Med Biol, 2002, 28(1): 59-68

[27] EckersleyRJ, ChinCT, BurnsPN. Optimising phase and amplitude modulation schemes for imaging microbubble contrast agents at low acoustic power. Ultrasound Med Biol, 2005, 31(2): 213-219

[28] GessnerRC, AylwardSR, DaytonPA. Mapping microvasculature with acoustic angiography yields quantifiable differences between healthy and tumor-bearing tissue volumes in a rodent model. Radiology, 2012, 264(3): 733-740

[29] KlibanovAL, RaschePT, HughesMS, et al.. Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles. Invest Radiol, 2004, 39(3): 187-195

[30] LinF, CachardC, MoriR, et al.. Ultrasound contrast imaging: influence of scatterer motion in multi-pulse techniques. IEEE Trans Ultrason Ferroelectr Freq Control, 2013, 60(10): 2065-2078

[31] PasovicM, DanilouchkineM, FaezT, et al.. Second harmonic inversion for ultrasound contrast harmonic imaging. Phys Med Biol, 2011, 56(11): 3163-3180

[32] Christensen-JeffriesK, BrowningRJ, TangMX, et al.. In Vivo Acoustic Super-Resolution and Super-Resolved Velocity Mapping Using Microbubbles. Ieee T Med Imaging, 2015, 34(2): 433-440

[33] DesaillyY, PierreJ, CoutureO, et al.. Resolution limits of ultrafast ultrasound localization microscopy. Phys Med Biol, 2015, 60(22): 8723-8740

[34] Christensen-JeffriesK, CoutureO, DaytonPA, et al.. Super-resolution Ultrasound Imaging. Ultrasound Med Biol, 2020, 46(4): 865-891

[35] CoutureO, HingotV, HeilesB, et al.. Ultrasound Localization Microscopy and Super-Resolution: A State of the Art. IEEE Trans Ultrason Ferroelectr Freq Control, 2018, 65(8): 1304-1320

[36] FröhlichE, MullerR, CuiX-W, et al.. Dynamic contrast-enhanced ultrasound for quantification of tissue perfusion. Journal of Ultrasound in Medicine, 2015, 34(2): 179-196

[37] BelcikJT, DavidsonBP, XieA, et al.. Augmentation of Muscle Blood Flow by Ultrasound Cavitation Is Mediated by ATP and Purinergic Signaling. Circulation, 2017, 135(13): 1240-1252

[38] GiannettiA, MatergiM, BiscontriM, et al.. Contrast-enhanced ultrasonography in clinical practice in Crohn’s disease: feasibility of destruction/replenishment method and software analysis. J Ultrasound, 2017, 20(4): 309-319

[39] BetzigE, PattersonGH, SougratR, et al.. Imaging intracellular fluorescent proteins at nanometer resolution. Science, 2006, 313(5793): 1642-1645

[40] RustMJ, BatesM, ZhuangX. Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM). Nat Methods, 2006, 3(10): 793-795

[41] van SlounRJ, SolomonO, BruceM, et al.Super-resolution ultrasound localization microscopy through deep learning, 2018

[42] LowerisonMR, HuangC, KimY, et al.. In Vivo Confocal Imaging of Fluorescently Labeled Microbubbles: Implications for Ultrasound Localization Microscopy. IEEE Trans Ultrason Ferroelectr Freq Control, 2020, 67(9): 1811-1819

[43] FoiretJ, ZhangH, IlovitshT, et al.. Ultrasound localization microscopy to image and assess microvasculature in a rat kidney. Sci Rep-Uk, 20177

[44] SongP, TrzaskoJD, ManducaA, et al.. Improved Super-Resolution Ultrasound Microvessel Imaging With Spatiotemporal Nonlocal Means Filtering and Bipartite Graph-Based Microbubble Tracking. IEEE Trans Ultrason Ferroelectr Freq Control, 2018, 65(2): 149-167

[45] HarputS, Christensen-JeffriesK, BrownJ, et al.. Two-Stage Motion Correction for Super-Resolution Ultrasound Imaging in Human Lower Limb. IEEE Trans Ultrason Ferroelectr Freq Control, 2018, 65(5): 803-814

[46] YuJ, LaveryL, KimK. Super-resolution ultrasound imaging method for microvasculature in vivo with a high temporal accuracy. Sci Rep, 2018, 8(1): 13918

[47] OpacicT, DencksS, TheekB, et al.. Motion model ultrasound localization microscopy for preclinical and clinical multiparametric tumor characterization. Nat Commun, 2018, 9(1): 1527

[48] DencksS, PiepenbrockM, OpacicT, et al.. Clinical Pilot Application of Super-Resolution US Imaging in Breast Cancer. IEEE Trans Ultrason Ferroelectr Freq Control, 2019, 66(3): 517-526

[49] ChenQ, YuJ, RushBM, et al.. Ultrasound super-resolution imaging provides a noninvasive assessment of renal microvasculature changes during mouse acute kidney injury. Kidney Int, 2020, 98(2): 355-365

[50] LinF, SheltonSE, EspindolaD, et al.. 3-D Ultrasound Localization Microscopy for Identifying Microvascular Morphology Features of Tumor Angiogenesis at a Resolution Beyond the Diffraction Limit of Conventional Ultrasound. Theranostics, 2017, 7(1): 196-204

[51] ZhuJ, RowlandEM, HarputS, et al.. 3D Super-Resolution US Imaging of Rabbit Lymph Node Vasculature In Vivo by Using Microbubbles. Radiology, 2019, 291(3): 642-650

[52] BercoffJ, MontaldoG, LoupasT, et al.. Ultrafast compound Doppler imaging: providing full blood flow characterization. IEEE Trans Ultrason Ferroelectr Freq Control, 2011, 58(1): 134-147

[53] TanterM, FinkM. Ultrafast imaging in biomedical ultrasound. IEEE Trans Ultrason Ferroelectr Freq Control, 2014, 61(1): 102-119

[54] CikesM, TongL, SutherlandGR, et al.. Ultrafast cardiac ultrasound imaging: technical principles, applications, and clinical benefits. JACC Cardiovasc Imaging, 2014, 7(8): 812-823

[55] HeilesB, CorreiaM, HingotV, et al.. Ultrafast 3D Ultrasound Localization Microscopy Using a 32 × 32 Matrix Array. IEEE Trans Med Imaging, 2019, 38(9): 2005-2015

[56] Christensen-JeffriesK, BrownJ, HarputS, et al.. Poisson Statistical Model of Ultrasound Super-Resolution Imaging Acquisition Time. IEEE Trans Ultrason Ferroelectr Freq Control, 2019, 66(7): 1246-1254

[57] HingotV, ErricoC, HeilesB, et al.. Microvascular flow dictates the compromise between spatial resolution and acquisition time in Ultrasound Localization Microscopy. Sci Rep., 2019, 9(1): 2456

[58] GhoshD, PengJ, BrownK, et al.. Super-Resolution Ultrasound Imaging of Skeletal Muscle Microvascular Dysfunction in an Animal Model of Type 2 Diabetes. J Ultrasound Med, 2019, 38(10): 2589-2599

[59] HuangC, LowerisonMR, TrzaskoJD, et al.. Short Acquisition Time Super-Resolution Ultrasound Microvessel Imaging via Microbubble Separation. Sci Rep, 2020, 10(1): 6007

[60] Christensen-JeffriesK, HarputS, BrownJ, et al.. Microbubble Axial Localization Errors in Ultrasound Super-Resolution Imaging. IEEE Trans Ultrason Ferroelectr Freq Control, 2017, 64(11): 1644-1654

[61] EisenhauerEA, TherasseP, BogaertsJ, et al.. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 2009, 45(2): 228-247

[62] LeeYJ, KimSH, KangBJ, et al.. Contrast-Enhanced Ultrasound for Early Prediction of Response of Breast Cancer to Neoadjuvant Chemotherapy. Ultraschall Med, 2019, 40(2): 194-204

[63] SirotkinaMA, MoiseevAA, MatveevLA, et al.. Accurate early prediction of tumour response to PDT using optical coherence angiography. Sci Rep, 2019, 9(1): 6492

[64] RibattiD, AnneseT, RuggieriS, et al.. Limitations of Anti-Angiogenic Treatment of Tumors. Transl Oncol, 2019, 12(7): 981-986

[65] LowerisonMR, HuangC, LucienF, et al.. Ultrasound localization microscopy of renal tumor xenografts in chicken embryo is correlated to hypoxia. Sci Rep, 2020, 10(1): 2478

[66] LekhtI, GulatiM, NayyarM, et al.. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone. Abdom Radiol (NY), 2016, 41(8): 1511-1521

[67] MeloniMF, ChiangJ, LaesekePF, et al.. Microwave ablation in primary and secondary liver tumours: technical and clinical approaches. Int J Hyperthermia, 2017, 33(1): 15-24

[68] WuH, PatelRB, ZhengY, et al.. Differentiation of benign periablational enhancement from residual tumor following radio-frequency ablation using contrast-enhanced ultrasonography in a rat subcutaneous colon cancer model. Ultrasound Med Biol, 2012, 38(3): 443-453

[69] YiH, CaiB, AiX, et al.. Early Identification of Residual Tumors following Microwave Ablation Using Contrast-Enhanced Ultrasonography in a Rabbit VX2 Liver Cancer Model. BioMed Research International, 2020, 2020: 2462058

[70] SainaniNI, GervaisDA, MuellerPR, et al.. Imaging after percutaneous radiofrequency ablation of hepatic tumors: Part 1, Normal findings. AJR Am J Roentgenol, 2013, 200(1): 184-193

[71] JiangT, ZhangX, DingJ, et al.. Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation. Int J Clin Exp Pathol, 2015, 8(11): 13945-13956

[72] ZhangN, WangL, ChaiZT, et al.. Incomplete radiofrequency ablation enhances invasiveness and metastasis of residual cancer of hepatocellular carcinoma cell HCCLM3 via activating beta-catenin signaling. PLoS One, 2014, 9(12): e115949

[73] KurodaH, AbeT, KakisakaK, et al.. Visualizing the hepatic vascular architecture using superb microvascular imaging in patients with hepatitis C virus: A novel technique. World J Gastroenterol, 2016, 22(26): 6057-6064

[74] RidolfiF, AbbattistaT, BusilacchiP, et al.. Contrast-enhanced ultrasound evaluation of hepatic microvascular changes in liver diseases. World J Gastroenterol, 2012, 18(37): 5225-5230

[75] HaimerlM, JungEM, BeyerLP, et al.. Chronic liver disease: Correlation of CEUS-based microperfusion and indocyanine green clearance. Clin Hemorheol Microcirc, 2015, 61(2): 195-204

[76] HaimerlM, PoelsterlS, BeyerLP, et al.. Chronic liver disease: Quantitative MRI vs CEUS-based microperfusion. Clin Hemorheol Microcirc, 2016, 64(3): 435-446

[77] LiN, DingH, FanP, et al.. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography. Ultrasound Med Biol, 2010, 36(7): 1066-1075

[78] FischerK, MeralFC, ZhangY, et al.. High-resolution renal perfusion mapping using contrast-enhanced ultrasonography in ischemia-reperfusion injury monitors changes in renal microperfusion. Kidney Int, 2016, 89(6): 1388-1398

[79] JeongS, ParkSB, KimSH, et al.. Clinical significance of contrast-enhanced ultrasound in chronic kidney disease: a pilot study. J Ultrasound, 2019, 22(4): 453-460

[80] SchinkelAFL, BoschJG, StaubD, et al.. Contrast-Enhanced Ultrasound to Assess Carotid Intraplaque Neovascularization. Ultrasound Med Biol, 2020, 46(3): 466-478

[81] RafailidisV, CharitantiA, TegosT, et al.. Contrast-enhanced ultrasound of the carotid system: a review of the current literature. J Ultrasound, 2017, 20(2): 97-109

[82] CombeB, LandeweR, DaienCI, et al.. 2016 update of the EULAR recommendations for the management of early arthritis. Ann Rheum Dis, 2017, 76(6): 948-959

[83] NellVP, MacholdKP, EberlG, et al.. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford), 2004, 43(7): 906-914

[84] BurmesterGR, PopeJE. Novel treatment strategies in rheumatoid arthritis. Lancet, 2017, 389(10086): 2338-2348

[85] SaleemB, BrownAK, KeenH, et al.. Should imaging be a component of rheumatoid arthritis remission criteria? A comparison between traditional and modified composite remission scores and imaging assessments. Ann Rheum Dis, 2011, 70(5): 792-798

[86] StrunkJ, HeinemannE, NeeckG, et al.. A new approach to studying angiogenesis in rheumatoid arthritis by means of power Doppler ultrasonography and measurement of serum vascular endothelial growth factor. Rheumatology (Oxford), 2004, 43(12): 1480-1483

[87] LeblondA, AllanoreY, AvouacJ. Targeting synovial neoangiogenesis in rheumatoid arthritis. Autoimmun Rev, 2017, 16(6): 594-601

[88] ZhuZ, YinY, ZhengK, et al.. Evaluation of synovial angiogenesis in patients with rheumatoid arthritis using (6)(8)Ga-PRGD2 PET/CT: a prospective proof-ofconcept cohort study. Ann Rheum Dis, 2014, 73(6): 1269-1272

[89] GuoH, WangQ, QiW, et al.. Assessing the development and treatment of rheumatoid arthritis using multiparametric photoacoustic and ultrasound imaging. J Biophotonics, 2019, 12(11): e201900127

[90] RednicN, TamasMM, RednicS. Contrast-enhanced ultrasonography in inflammatory arthritis. Med Ultrason, 2011, 13(3): 220-227

[91] OhrndorfS, HenschA, NaumannL, et al.. Contrast-enhanced ultrasonography is more sensitive than grayscale and power Doppler ultrasonography compared to MRI in therapy monitoring of rheumatoid arthritis patients. Ultraschall Med, 2011, 32(Suppl2): E38-44

[92] Ten CateDF, LuimeJJ, SwenN, et al.. Role of ultrasonography in diagnosing early rheumatoid arthritis and remission of rheumatoid arthritis—a systematic review of the literature. Arthritis Res Ther, 2013, 15(1): R4

[93] KlauserA, DemharterJ, De MarchiA, et al.. Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group. Eur Radiol, 2005, 15(12): 2404-2410

[94] KlauserAS, FranzM, Bellmann WeilerR, et al.. Contrast-enhanced ultrasonography for the detection of joint vascularity in arthritis—subjective grading versus computer-aided objective quantification. Ultraschall Med, 2011, 32(Suppl2): E31-37

[95] RizzoG, RaffeinerB, CoranA, et al.. Pixel-based approach to assess contrast-enhanced ultrasound kinetics parameters for differential diagnosis of rheumatoid arthritis. J Med Imaging (Bellingham), 2015, 2(3): 034503

[96] TamasMM, BondorCI, RednicN, et al.. The evolution of time-intensity curves of contrast enhanced ultrasonography in early arthritis patients with wrist involvement. Med Ultrason, 2015, 17(3): 345-351

[97] StramareR, CoranA, FaccinettoA, et al.. MR and CEUS monitoring of patients with severe rheumatoid arthritis treated with biological agents: a preliminary study. Radiol Med, 2014, 119(6): 422-431

[98] AletahaD, WardMM, MacholdKP, et al.. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum, 2005, 52(9): 2625-2636

[99] WellsGA, BoersM, SheaB, et al.. Minimal disease activity for rheumatoid arthritis: a preliminary definition. J Rheumatol, 2005, 32(10): 2016-2024

[100] RafailidisV, HuangDY, YusufGT, et al.. General principles and overview of vascular contrast-enhanced ultrasonography. Ultrasonography, 2020, 39(1): 22-42

[101] KolinkoY, KrakorovaK, CendelinJ, et al.. Microcirculation of the brain: morphological assessment in degenerative diseases and restoration processes. Rev Neurosci, 2015, 26(1): 75-93

[102] NoumbissiME, GalassoB, StinsMF. Brain vascular heterogeneity: implications for disease pathogenesis and design of in vitro blood-brain barrier models. Fluids Barriers CNS, 2018, 15(1): 12

[103] HanF. Cerebral microvascular dysfunction and neurodegeneration in dementia. Stroke Vasc Neurol, 2019, 4(2): 105-107

[104] HwangM, SridharanA, DargeK, et al.. Novel Quantitative Contrast-Enhanced Ultrasound Detection of Hypoxic Ischemic Injury in Neonates and Infants: Pilot Study 1. J Ultrasound Med, 2019, 38(8): 2025-2038

[105] HwangM. Introduction to contrast-enhanced ultrasound of the brain in neonates and infants: current understanding and future potential. Pediatr Radiol, 2019, 49(2): 254-262

[106] MarescaD, CorreiaM, VillemainO, et al.. Noninvasive Imaging of the Coronary Vasculature Using Ultrafast Ultrasound. JACC Cardiovasc Imaging, 2018, 11(6): 798-808

[107] CalmacL, BatailaV, DragoescuB, et al.. Microvascular (dys)Function in Stable Coronary Artery Disease: Cross Talk with Epicardial Segments. Curr Pharm Des, 2018, 24(25): 2900-2905

[108] PorterTR, FeinsteinSB, Ten CateFJ, et al.. New Applications in Echocardiography for Ultrasound Contrast Agents in the 21st Century. Ultrasound Med Biol, 2020, 46(5): 1071-1081

[109] LiCH, WangHD, HuJJ, et al.. The monitoring of microvascular liver blood flow changes during ischemia and reperfusion using laser speckle contrast imaging. Microvasc Res, 2014, 94: 28-35

[110] NormanPE, EikelboomJW, HankeyGJ. Peripheral arterial disease: prognostic significance and prevention of atherothrombotic complications. Med J Aust, 2004, 181(3): 150-154

[111] RosolovaH, PetrlovaB, SimonJ, et al.. Macrovascular and microvascular complications in type 2 diabetes patients. Vnitr Lek, 2008, 54(3): 229-237